Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 1:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 897 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: No Intervention Given Clear all

Conditions: HIV Infections
Interventions: myDEx, NTHP; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 24 Years · Male only
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Adrenocortical Adenoma, Endometrial Stromal Sarcomas
Interventions: MRI, CT or ultrasound was permitted if MRI was contraindicated, Dexamethasone Supression Test, Sonogram, Biopsy, BGG492; Procedure · Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 4
States / cities: Tallahassee, Florida • Baltimore, Maryland • Hoffman, New Jersey + 1 more

Conditions: Chorioamnionitis, Intrapartum Fever, Intra-amniotic Infection
Interventions: Standard Antibiotic Treatment, No Antibiotic Treatment; Drug · Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 50 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Asthma, Wheezing, In Utero Nicotine, Pulmonary Function
Interventions: No current intervention; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 6 Months to 11 Years
Enrollment: 395 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 2
States / cities: Indianapolis, Indiana • Portland, Oregon

Conditions: Obesity
Interventions: Communications, Pricing, Combined (Communications & Pricing); Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 21 Years to 100 Years
Enrollment: 444 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Suicidal Ideation, Major Depressive Disorder
Interventions: Dialectical Behavior Therapy Skills (DBT-S) Groups, Wait List-Treatment as Usual, No intervention-treatment as usual; Behavioral
Lead sponsor: Maurizio Fava, MD; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cystic Fibrosis
Interventions: BH4 5mg, BH4 20mg, Antioxidant Cocktail; Drug · Dietary Supplement
Lead sponsor: Augusta University; Other
Eligibility: 7 Years and older
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Glioblastoma
Interventions: Pembrolizumab, HSPPC-96, Temozolomide, Placebo, Surgery; Drug · Biological · Other + 1 more
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Post Operative Pain, Impacted Third Molar Tooth, Muscle Pain
Interventions: Temporo-masseteric Nerve Block Injection, Oral Pain Medications only; Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Peripheral Artery Disease
Interventions: No Intervention-Clinical Assessments only; Diagnostic Test
Lead sponsor: Columbia University; Other
Eligibility: 35 Years to 80 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Anesthesia
Interventions: Dural puncture epidurals (DPE), Traditional epidurals (EPI), Combined-spinal epidural technique (CSE); Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Labor Pain
Interventions: iPod (Music/video games); Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 253 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Crohn Disease
Interventions: Ustekinumab 90 mg, Ustekinumab 4.5 mg/kg, Placebo SC, Placebo IV; Drug
Lead sponsor: Centocor, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 50
States / cities: Scottsdale, Arizona • Anaheim, California • Sacramento, California + 47 more

Conditions: Cerebral Palsy
Interventions: SurePace Powered Walker User; Device
Lead sponsor: Barron Associates, Inc.; Industry
Eligibility: 6 Years to 75 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Health Care Utilization, Depression, Anxiety, Subjective Wellbeing
Interventions: Medical debt forgiveness; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 15,008 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hypertension
Interventions: Virtual Hypertension Clinic; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 25 Years to 65 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Neonatal Abstinence Syndrome
Interventions: Clonidine HCL, saline; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 5 Days to 90 Days
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Gastrointestinal Malignancy
Interventions: Mobility and Activity Training; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 60 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 2
States / cities: Ann Arbor, Michigan

Conditions: Anesthesia, Hypotension
Interventions: Electronic alert to SLUScore increase; Behavioral
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8
Interventions: Bendamustine, Biopsy, Biospecimen Collection, Bone Scan, Bridge Therapy, Computed Tomography, Cyclophosphamide, Echocardiography, Fludarabine, Leukapheresis, Multigated Acquisition Scan, T-cell Receptor-engineered T-cells, X-Ray Imaging; Drug · Procedure · Biological
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Postoperative Nausea
Interventions: Ondansetron; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Malignant Neoplasms of Independent (Primary) Multiple Sites
Interventions: Tongue Assessment, Stool Sample, Questionnaires, Holter Monitor, Yogurt; Other · Behavioral · Device
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: ADHD
Interventions: OROS methylphenidate, No intervention; Drug · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 12 Years to 18 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Sarcoma
Interventions: dactinomycin, cyclophosphamide, etoposide, ifosfamide, vincristine sulfate, Conventional Surgery, MESNA (mercaptoethane sulfonate), Filgrastim; Biological · Drug · Procedure
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 2 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 64
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Downey, California + 57 more

Search by objective public record fields.

Development of a Tailored HIV Prevention Intervention for Young Men

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492

Intrapartum Fever: Antibiotics Versus no Treatment

Vitamin C Supplementation to Pregnant Smokers: Follow-up of 2 Randomized Trials Plus Changes in DNA Methylation

Multi-level Communications and Access Strategies to Improve the Food Environment

Adaptation of Dialectical Behavior Therapy Skills-Groups for Individuals With Suicidal Ideation and Depression

Cystic Fibrosis and Endothelial Function: At Rest and During Exercise

Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)

Jaw Muscle Pain Post Wisdom Molar Surgery

Microvascular Reactivity in Peripheral Artery Disease

Epidural Technique: Does it Really Matter to the Patient?

Music and/or Video Games During Labor

A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease

Intelligent and Adaptive Control Applied to Powered Walkers

Health and Health Care Utilization Effects of Medical Debt Forgiveness

Virtual Hypertension Clinic

Clonidine to Treat Iatrogenic-induced Opioid Dependence in Infants

Mobility and Activity Training (MAT) to Optimize Outcomes for Older Adult Abdominal Surgery Patients

Prospective Trial of Alerting to Extended Hypotensive Exposures on Long-Term Outcome After Surgery

Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer

How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women

The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms

Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate

Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma